An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT05089435

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Sigknow Biomedical Co., Ltd. (from the registry)
Registry
  • NCT NCT05089435
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05089435. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-03-28 (actual); primary completion 2023-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients
Condition
Embolic Stroke of Undetermined Source
Intervention (Device)
EZYPRO® ECG Recorder
Lead sponsor
Sigknow Biomedical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05089435
Content hash
9dc4f2507df5d175e1bdf21896486fcc51472c86fbcee7a6561f0c5b2bbf39d5